Ken is an intellectual property attorney practicing in the patent prosecution and counseling space. He provides creative and carefully considered patent strategies designed to maximize patent portfolio value. In addition to patent procurement, Ken counsels lenders and investors in assessing the value of patent assets through due diligence reviews, including validity analyses, freedom-to-operate analyses, and in-licensed technology investigations.
Ken has extensive experience in patenting a wide range of life sciences technologies including antibody therapeutics, small molecule modulators, diagnostics, immuno-oncotherapies, pharmaceutical formulations, gene editing, siRNA therapeutics, stem cell therapies, nanotechnologies, and machine learning and AI in Life Sciences technologies. He enjoys working closely with scientists to translate their discoveries to high value patent assets.
Ken works with a diverse set of clients, from research institutions to pre-funded startups to some of the world’s largest life sciences companies. He carefully tailors patent strategies to the specific business needs of each client while considering the ever-changing global patent case law landscape.
viewpoints
News & Press
Ken is an intellectual property attorney practicing in the patent prosecution and counseling space. He provides creative and carefully considered patent strategies designed to maximize patent portfolio value. In addition to patent procurement, Ken counsels lenders and investors in assessing the value of patent assets through due diligence reviews, including validity analyses, freedom-to-operate analyses, and in-licensed technology investigations.
Recognition & Awards
Ken is an intellectual property attorney practicing in the patent prosecution and counseling space. He provides creative and carefully considered patent strategies designed to maximize patent portfolio value. In addition to patent procurement, Ken counsels lenders and investors in assessing the value of patent assets through due diligence reviews, including validity analyses, freedom-to-operate analyses, and in-licensed technology investigations.
Involvement
Recent Insights
Mintz announced that Members Fred Hernandez and Ken Jenkins were named 2024 “Leaders of Influence in Life Sciences” by San Diego Business Journal (SDBJ) which recognizes individuals who are making significant contributions to the advancement of science, healthcare, and innovation in San Diego.
187 Mintz attorneys have been recognized by Best Lawyers® in the 2025 edition of The Best Lawyers in America©. Notably, three Mintz attorneys received 2025 “Lawyer of the Year” awards, and 64 firm attorneys were included in the 2025 edition of Best Lawyers: Ones to Watch.
